This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1988;28(1):46-9.

doi: 10.1007/BF00372528.

The two-dimensional migration pattern of the single HLA-DR beta chain expressed in DRw8 haplotypes is not fully predictive of its activity in antigen presentation

M Bouillot¹, J Choppin, G Sterkers, C Freidel, L Gebuhrer, H Betuel, J P Levy

Affiliations

PMID: 3378836
DOI: 10.1007/BF00372528

The two-dimensional migration pattern of the single HLA-DR beta chain expressed in DRw8 haplotypes is not fully predictive of its activity in antigen presentation

M Bouillot et al. Immunogenetics. 1988.

. 1988;28(1):46-9.

doi: 10.1007/BF00372528.

Authors

M Bouillot¹, J Choppin, G Sterkers, C Freidel, L Gebuhrer, H Betuel, J P Levy

Affiliation

¹ INSERM U152, CNRS UA 628, Hôpital Cochin, Paris, France.

PMID: 3378836
DOI: 10.1007/BF00372528

No abstract available

PubMed Disclaimer

Similar articles

Two variants of DRw52, DR3, and DQw2 specificities distinguish two different DR3-bearing extended haplotypes.
Dasgupta JD, Relias V, Awdeh ZL, Alper CA, Yunis EJ. Dasgupta JD, et al. Hum Immunol. 1988 Feb;21(2):133-42. doi: 10.1016/0198-8859(88)90088-2. Hum Immunol. 1988. PMID: 2835344
DR-restricted T-cell reactivities associated with the Dw19 specificity can be directed against the products of either locus DRB3 (DRw52c) or locus DRB1.
Zeliszewski D, Tiercy JM, Dorval I, Kaplan C, Mach B, Sterkers G. Zeliszewski D, et al. Hum Immunol. 1990 Aug;28(4):345-53. doi: 10.1016/0198-8859(90)90029-o. Hum Immunol. 1990. PMID: 2391250
Functional polymorphism of the HLA-DR beta III chain.
Sheehy MJ, Rowe JR, Koning F, Jorgensen L. Sheehy MJ, et al. Hum Immunol. 1988 Jan;21(1):49-61. doi: 10.1016/0198-8859(88)90080-8. Hum Immunol. 1988. PMID: 2452815
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?
Altomonte M, Fonsatti E, Visintin A, Maio M. Altomonte M, et al. Oncogene. 2003 Sep 29;22(42):6564-9. doi: 10.1038/sj.onc.1206960. Oncogene. 2003. PMID: 14528281 Review.
Class II major histocompatibility complex and organ specific autoimmunity in man.
Foulis AK. Foulis AK. J Pathol. 1986 Sep;150(1):5-11. doi: 10.1002/path.1711500103. J Pathol. 1986. PMID: 2946837 Review.

See all similar articles

Cited by

A cellular and functional split in the DRw8 haplotype is due to a single amino acid replacement (DR beta ser 57- asp 57).
Jonsson AK, Andersson L, Rask L. Jonsson AK, et al. Immunogenetics. 1989;29(5):308-16. doi: 10.1007/BF00352840. Immunogenetics. 1989. PMID: 2497068

References

1. J Immunol. 1980 Jul;125(1):293-9 - PubMed
1. J Biol Chem. 1985 Feb 10;260(3):1927-36 - PubMed
1. Hum Immunol. 1987 Nov;20(3):233-47 - PubMed
1. J Immunol. 1985 Sep;135(3):2149-55 - PubMed
1. Hum Immunol. 1985 Jan;12(1):9-21 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Research Materials
- NCI CPTC Antibody Characterization Program